4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001749432-26-000004
CHIEF LEGAL OFFICER sold 40,000 shares at an average $23.79 ($951,503)
- CHIEF LEGAL OFFICER acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-03 | Option exercise | +15,000 | $4.37 | $65,550 | 15,000 | D: show line 1 in the form |
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-03 | Sale | −15,000 | $23.01 | $345,150 | 0 | D: show line 2 in the form |
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-04 | Option exercise | +25,000 | $4.37 | $109,250 | 25,000 | D: show line 3 in the form |
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-04 | Sale | −24,767 | $24.25 | $600,600 | 233 | D: show line 4 in the form |
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-04 | Sale | −233 | $24.69 | $5,753 | 0 | D: show line 5 in the form |
| Open-market sales · 40,000 sh · avg $23.79 · $951,503 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-03 | Option exercise · Stock Option (Right to Buy) | −15,000 | 435,000 | D: show line 6 in the form | ||
| Mitchell Shawnte CHIEF LEGAL OFFICER | 2026-03-04 | Option exercise · Stock Option (Right to Buy) | −25,000 | 410,000 | D: show line 7 in the form |
Loading xslF345X05/form4-03052026_080301.xml…